William Silbey - UCB SA Exec Counsel

All Insiders . Belgium . 
Stock . UCB SA . Stakeholders . Insider . William Silbey
UCB Stock  EUR 169.90  5.55  3.38%   

Insider

William Silbey is Exec Counsel of UCB SA
Age 64
Phone32 2 559 99 99
Webhttps://www.ucb.com

UCB SA Management Efficiency

The company has return on total asset (ROA) of 0.0468 % which means that it generated a profit of $0.0468 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1069 %, meaning that it generated $0.1069 on every $100 dollars invested by stockholders. UCB SA's management efficiency ratios could be used to measure how well UCB SA manages its routine affairs as well as how well it operates its assets and liabilities.
UCB SA has accumulated 1.97 B in total debt with debt to equity ratio (D/E) of 23.9, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. UCB SA has a current ratio of 1.29, suggesting that it may not have the ability to pay its financial obligations in time and when they become due. Debt can assist UCB SA until it has trouble settling it off, either with new capital or with free cash flow. So, UCB SA's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like UCB SA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for UCB to invest in growth at high rates of return. When we think about UCB SA's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Filip Coremansageas SANV
59
Veerle Verbessemageas SANV
N/A
Jerry Bataageas SANV
N/A
Xavier CPAGroep Brussel Lambert
55
Laurence FlammeGroep Brussel Lambert
N/A
David MoucheronKBC Groep NV
50
Johan ThiersKBC Groep NV
N/A
Antonio Bosqueageas SANV
60
Augusto DonfrancescoSolvay SA
64
Sophia HarmsGroep Brussel Lambert
N/A
Dominikus GolsongSolvay SA
68
Katia WaegemansAckermans Van Haaren
N/A
Bernard DelpitGroep Brussel Lambert
59
Hari RajmohanAckermans Van Haaren
N/A
Viviane HuybrechtKBC Groep NV
N/A
Emmanuel Grimbergenageas SANV
55
Count QuevrinGroep Brussel Lambert
N/A
Marc CholletSolvay SA
59
Pieter BevernageAckermans Van Haaren
55
Pascal ReynaertsGroep Brussel Lambert
N/A
Geoffroy RaskinSolvay SA
N/A
UCB SA, a biopharmaceutical company, researches, develops, manufactures, sells, and distributes biopharmaceutical solutions for people living with neurology and immunology conditions. The company was founded in 1928 and is headquartered in Brussels, Belgium. UCB SA operates under Biotechnology classification in Belgium and is traded on Brussels Stock Exchange. It employs 6828 people. UCB SA (UCB) is traded on Euronext Brussels in Belgium and employs 8,600 people.

Management Performance

Return On Equity0.11
Return On Asset0.0468

UCB SA Leadership Team

Elected by the shareholders, the UCB SA's board of directors comprises two types of representatives: UCB SA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of UCB. The board's role is to monitor UCB SA's management team and ensure that shareholders' interests are well served. UCB SA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, UCB SA's outside directors are responsible for providing unbiased perspectives on the board's policies.
Sandrine CFA, Ex CFO
Emmanuel Caeymaex, Executive Vice President Immunology - Patient Value Unit Head
William Silbey, Exec Counsel
Pr LowFriedrich, Chief VP
Charl Zyl, Executive Vice President Head of Patient Value Operations, Member of the Executive Committee
Kirsten LundJurgensen, Ex Solutions
Caroline Vancoillie, Chief Functions
JeanLuc Fleurial, Executive Vice President Chief Talent Officer, Member of the Executive Committee
JeanChristophe Tellier, Chairman of the Executive Committee, CEO

UCB Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is UCB SA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.11
Return On Asset0.0468
Profit Margin0.15 %
Operating Margin0.19 %
Current Valuation15.81 B
Shares Outstanding189.96 M
Shares Owned By Insiders38.03 %
Shares Owned By Institutions40.78 %
Price To Earning17.19 X
Price To Book1.55 X

Pair Trading with UCB SA

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if UCB SA position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in UCB SA will appreciate offsetting losses from the drop in the long position's value.

Moving against UCB Stock

  0.68CFEB Compagnie d Entreprises Earnings Call TomorrowPairCorr
  0.67BNB Banque nationalePairCorr
The ability to find closely correlated positions to UCB SA could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace UCB SA when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back UCB SA - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling UCB SA to buy it.
The correlation of UCB SA is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as UCB SA moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if UCB SA moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for UCB SA can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for UCB Stock Analysis

When running UCB SA's price analysis, check to measure UCB SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UCB SA is operating at the current time. Most of UCB SA's value examination focuses on studying past and present price action to predict the probability of UCB SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UCB SA's price. Additionally, you may evaluate how the addition of UCB SA to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY